Comparable-Patient Intelligence for Oncology

Transparent match drivers
Consistent scoring
Observational evidence

OncoTwin finds the most similar real-world patients ("twins") using clinico-genomic similarity and network algorithms—then summarizes treatment journeys and observed outcomes with transparent rationale.

What powers OncoTwin

Three pillars working together to surface meaningful clinical insights

Similarity Matching

Weighted similarity across clinical context, biomarkers, and genomics—with auditable drivers of match and confidence bands.

Network Intelligence

Graph methods stabilize retrieval and reduce one-off coincidences—surfacing clusters of related cases, not just a single nearest neighbor.

Peer Evidence (Statistics)

Cohort-level rates among similar patients (with n): durability, early failure, and outcome context by treatment class.

How this works

Simple, streamlined process from sample to actionable insights

Normalize

Standardize clinical + biomarker + genomic representations.

Constrain

Stage and driver cohort alignment to avoid implausible comparisons.

Score

Tuned weights + subcohort logic + co-alteration penalties.

Explain

Top twins + match drivers + peer evidence panel (n, confidence).

WHAT YOU GET

AI-Powered Clinical Decision Support

Experience the future of evidence-backed oncology. OncoTwin helps oncologists move beyond static reports by matching each patient’s genomic and clinical profile to thousands of global outcomes—delivering evidence-backed treatment options in real time.

Real-World Outcome Intelligence
AI trained on diverse global datasets to provide treatment paths supported by real patient outcomes.
Digital Twin Patient Models
A virtual model of each patient that predicts response patterns and simulates therapy options.
Personalized Therapy Recommendations
Insights tailored to genomic alterations, biomarkers, comorbidities, and treatment history.
Adaptive Evidence Engine
Continuously updated insights incorporating the latest studies, guidelines, and real-world data.
WHAT YOU GET

The Twin Report

A structured, analytically rigorous patient similarity report designed for clinical interpretability and reproducibility.

Top-matched patient twins with quantified similarity scores and contributing match features


Comparative treatment trajectories, including lines of therapy, treatment duration, and progression-related signals


Peer evidence summary, presenting outcome rates with corresponding cohort size and statistical confidence indicators


Risk and limitation annotations, highlighting data sparsity, potential confounding factors, and completeness considerations

WHAT YOU GET

Molecular Tumour Board Enablement

A structured, data-integrated workspace designed to support multidisciplinary molecular tumour board discussions through unified, evidence-contextualized case review.

Integrated case view consolidating genomic findings, clinical history, biomarkers, and prior treatments in a single standardized format


Evidence contextualization layer linking molecular alterations to guidelines, literature, and real-world cohort signals


Twin-based cohort insights providing outcome context from clinically similar patients without prescriptive inference

Trust & guardrails

Decision support, not a clinical directive

Observational evidence (not guaranteed outcomes; not causal claims)

Transparent rationale for every match

Confidence-aware: small samples are flagged